Company Overview
Snapshot
Founded in January 2000, Ardia operates with 1–10 employees. The company focuses on developing patented medical systems for tumor diagnosis, having developed its core platform, WisArdia, to extract and reduce pathology data.
Business overview
Ardia develops proprietary medical systems and software tools designed to assist pathologists in the detection and diagnosis of tumors. Its core platform, WisArdia, extracts and standardizes pathology data from biopsies. The company's product suite, including ArdiaLog, ArdiaExpert, and ArdiaScan, provides computer-aided decision support, peer consultation services, and automated screening for metastases. Ardia serves the healthcare industry, specifically hospitals and pathology departments, operating within the Digital Health and Medical Technologies sectors, with a focus on diagnostics and decision support.
Log in to access full profile ›Company Intelligence Q&A
- What is Ardia's primary focus?
- Ardia specializes in developing patented medical systems and software tools to aid pathologists in the detection and diagnosis of tumors.
- What is the WisArdia platform?
- WisArdia is Ardia's core platform that extracts and reduces pathology data from biopsies into a standard file format.
- How does ArdiaLog support pathologists?
- ArdiaLog is a computer-aided decision support system designed by Ardia to help pathologists achieve more consistent and accurate decisions when analyzing and grading suspicious areas on histological slides.
- What is the purpose of ArdiaExpert?
- ArdiaExpert is an internet service provided by Ardia for peer pathologists' consultation and support.
- What problem does ArdiaScan address?
- ArdiaScan is intended for automatic or semi-automatic screening and detection of metastases and micro-metastases in lymph gland biopsies, addressing a routine and time-consuming process in cancer diagnosis.